Literature DB >> 9561309

Psychological functioning in primary progressive versus secondary progressive multiple sclerosis.

L Vleugels1, L Pfennings, F Pouwer, L Cohen, P Ketelaer, C Polman, G Lankhorst, H van der Ploeg.   

Abstract

Psychological functioning in two types of multiple sclerosis (MS) patients is assessed: primary progressive (PP) and secondary progressive (SP) patients. On the basis of differences in clinical course and underlying pathology we hypothesized that primary progressive patients and secondary progressive patients might have different psychological functioning. Seventy patients treated in an MS centre were examined cross-sectionally. Forty had an SP course of MS and 30 a PP course. The 33 male and 37 female patients had a mean age of 48.4 years (SD 11.2) and mean age of onset of MS of 30.7 years (SD 11.1). Patients completed questionnaires measuring among others the following aspects of psychological functioning: depression (BDI, SCL-90), anxiety (STAI, SCL-90), agoraphobia (SCL-90), somatic complaints (SCL-90), hostility (SCL-90) and attitude towards handicap (GHAS). Patients with a PP-MS scored significantly better on 5 out of 14 subscales than patients with SP-MS (p < .05). On the basis of our operationalizations of psychological functioning, the findings support the conclusion that on average 18 years after diagnosis of MS, amongst patients attending an MS unit, primary progressive patients were found to have better psychological functioning.

Entities:  

Mesh:

Year:  1998        PMID: 9561309     DOI: 10.1111/j.2044-8341.1998.tb01370.x

Source DB:  PubMed          Journal:  Br J Med Psychol        ISSN: 0007-1129


  5 in total

1.  Factor structure of the Disability and Impact Profile in patients with multiple sclerosis.

Authors:  L Cohen; F Pouwer; L E Pfennings; G J Lankhorst; H M van der Ploeg; C H Polman; H J Adèr; A Jønnson; L Vleugels
Journal:  Qual Life Res       Date:  1999       Impact factor: 4.147

2.  Characterization of functioning in multiple sclerosis using the ICF.

Authors:  Lisa Holper; Michaela Coenen; Andrea Weise; Gerold Stucki; Alarcos Cieza; Jürg Kesselring
Journal:  J Neurol       Date:  2010-01       Impact factor: 4.849

3.  Multiple Sclerosis Impact Scale (MSIS-29): reliability and validity in hospital based samples.

Authors:  A Riazi; J C Hobart; D L Lamping; R Fitzpatrick; A J Thompson
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-12       Impact factor: 10.154

4.  Multiple challenges for people after transitioning to secondary progressive multiple sclerosis: a qualitative study.

Authors:  Angeliki Bogosian; Myfanwy Morgan; Rona Moss-Morris
Journal:  BMJ Open       Date:  2019-03-08       Impact factor: 2.692

5.  The late onset of emotional distress in people with progressive multiple sclerosis during the Covid-19 pandemic: longitudinal findings from the CogEx study.

Authors:  Anthony Feinstein; Maria Pia Amato; Giampaolo Brichetto; Jeremy Chataway; Nancy D Chiaravalloti; Gary Cutter; Ulrik Dalgas; John DeLuca; Rachel Farrell; Peter Feys; Massimo Filippi; Jennifer Freeman; Matilde Inglese; Cecilia Meza; Robert W Motl; Maria Assunta Rocca; Brian M Sandroff; Amber Salter
Journal:  J Neurol       Date:  2022-08-08       Impact factor: 6.682

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.